Gastrointestinal Stromal Tumor (GIST): ASCO Tumor Boards

This is a case-based activity that includes a discussion of a 60-year-old woman with no significant medical history who presented with 3 days of persistent right upper quadrant abdominal pain.  Examination was notable for mild right upper quadrant tenderness and a soft, non-distended abdomen.

At the end of this course, learners should be able to:

  • Identify the key pathologic and histologic features in GIST to determine appropriate use of adjuvant imatinib following surgical resection
  • Define the role of genetic mutation testing in GIST and how it impacts treatment selection
  • Describe the pivotal clinical trials for treatment of metastatic GIST

Continuing Education Credit: 1.5 Credits/Points are available for participation in this course. Certificate and credit types include:

  • AMA PRA Category 1 Credits
  • ABIM MOC Points
  • CNE Contact Hours
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.

Important Note: This course expires on July 18, 2020. Learners must complete all necessary course components by this date. This course is available as part of the 2018 ASCO Tumor Boards bundle.